Dr. Paola Ghione, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,046 | 5 | 78.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,610 | 1 | 12.8% |
| Travel and Lodging | $910.69 | 2 | 4.5% |
| Food and Beverage | $800.67 | 12 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ADC Therapeutics America, Inc. | $13,454 | 10 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $2,720 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $1,528 | 1 | $0 (2021) |
| SECURA BIO, INC. | $1,500 | 1 | $0 (2022) |
| Kyowa Kirin, Inc. | $818.75 | 1 | $0 (2021) |
| Genmab U.S., Inc. | $155.14 | 2 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $127.32 | 1 | $0 (2024) |
| Genentech USA, Inc. | $37.05 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $27.37 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,995 | 14 | ADC Therapeutics America, Inc. ($11,054) |
| 2023 | $2,499 | 2 | ADC Therapeutics America, Inc. ($2,400) |
| 2022 | $1,527 | 2 | SECURA BIO, INC. ($1,500) |
| 2021 | $2,346 | 2 | Daiichi Sankyo Inc. ($1,528) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $127.32 | General |
| 12/09/2024 | Genentech USA, Inc. | Columvi (Biological), Lucentis, Polivy | Food and Beverage | In-kind items and services | $37.05 | General |
| Category: BioOncology | ||||||
| 12/08/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $56.34 | General |
| Category: Oncology | ||||||
| 12/08/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $46.50 | General |
| 10/31/2024 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| 10/17/2024 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,610.00 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Food and Beverage | In-kind items and services | $110.21 | General |
| Category: Oncology | ||||||
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $346.69 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $120.03 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $60.02 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $50.01 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $43.01 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| 09/17/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $564.00 | General |
| 06/14/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $98.80 | General |
| Category: Oncology | ||||||
| 03/22/2023 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $27.37 | General |
| 03/10/2022 | SECURA BIO, INC. | COPIKTRA (Drug), COPIKTRA, COPIKTRA | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Hematology and Oncology | ||||||
| 12/09/2021 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $1,527.50 | General |
| 11/16/2021 | Kyowa Kirin, Inc. | POTELIGEO (Drug) | Consulting Fee | Cash or cash equivalent | $818.75 | General |
| Category: MONOCLONAL ANTIBODY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 184 | 282 | $184,835 | $30,275 |
| 2022 | 4 | 108 | 149 | $68,591 | $13,950 |
| 2021 | 6 | 153 | 233 | $70,614 | $18,440 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 109 | 147 | $107,310 | $17,236 | 16.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 62 | $32,240 | $6,574 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 62 | $33,790 | $4,679 | 13.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $11,495 | $1,785 | 15.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 38 | $28,120 | $5,026 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 20 | $7,725 | $2,284 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 24 | $6,391 | $1,837 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 20 | $10,900 | $1,768 | 16.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 29 | $8,658 | $1,599 | 18.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 18 | $6,797 | $1,436 | 21.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 43 | 48 | $17,748 | $5,300 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 50 | 56 | $14,228 | $4,316 | 30.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 60 | $17,020 | $3,366 | 19.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 27 | $9,385 | $2,177 | 23.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 13 | 13 | $7,020 | $1,888 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 29 | $5,213 | $1,393 | 26.7% |
About Dr. Paola Ghione, MD
Dr. Paola Ghione, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1730740556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paola Ghione, MD has received a total of $20,368 in payments from pharmaceutical and medical device companies, with $13,995 received in 2024. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($16,046).
As a Medicare-enrolled provider, Ghione has provided services to 445 Medicare beneficiaries, totaling 664 services with total Medicare billing of $62,665. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Medical Oncology
- Location Buffalo, NY
- Active Since 06/24/2019
- Last Updated 05/27/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1730740556
Products in Payments
- Tazverik (Drug) $2,720
- COPIKTRA (Drug) $1,500
- POTELIGEO (Drug) $818.75
- Epkinly (Drug) $155.14
- Columvi (Biological) $37.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Buffalo
Sandra Sieminski, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $64,808
Carter Lindborg, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $40,328
Dr. Thomas Suchy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,872
Vincent Croglio, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $15,454
Steven Green, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,842
Ashish Bhatia, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $13,619